Oakbrook Investments’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,830
Closed -$738K 180
2019
Q4
$738K Sell
4,830
-1,225
-20% -$187K 0.15% 206
2019
Q3
$802K Buy
6,055
+1,300
+27% +$172K 0.05% 284
2019
Q2
$675K Sell
4,755
-975
-17% -$138K 0.04% 336
2019
Q1
$832K Buy
5,730
+50
+0.9% +$7.26K 0.05% 285
2018
Q4
$643K Sell
5,680
-812
-13% -$91.9K 0.04% 313
2018
Q3
$873K Buy
6,492
+1,550
+31% +$208K 0.05% 323
2018
Q2
$555K Sell
4,942
-555
-10% -$62.3K 0.04% 331
2018
Q1
$587K Buy
5,497
+320
+6% +$34.2K 0.04% 321
2017
Q4
$567K Buy
5,177
+660
+15% +$72.3K 0.04% 331
2017
Q3
$488K Buy
4,517
+400
+10% +$43.2K 0.03% 347
2017
Q2
$416K Buy
+4,117
New +$416K 0.03% 362
2017
Q1
Sell
-5,042
Closed -$384K 537
2016
Q4
$384K Buy
5,042
+150
+3% +$11.4K 0.03% 408
2016
Q3
$408K Hold
4,892
0.02% 392
2016
Q2
$403K Buy
4,892
+1,050
+27% +$86.5K 0.02% 405
2016
Q1
$292K Sell
3,842
-500
-12% -$38K 0.02% 438
2015
Q4
$349K Buy
4,342
+100
+2% +$8.04K 0.02% 411
2015
Q3
$269K Hold
4,242
0.02% 463
2015
Q2
$298K Buy
4,242
+150
+4% +$10.5K 0.02% 449
2015
Q1
$324K Buy
4,092
+200
+5% +$15.8K 0.02% 454
2014
Q4
$248K Hold
3,892
0.01% 499
2014
Q3
$233K Sell
3,892
-400
-9% -$23.9K 0.01% 477
2014
Q2
$230K Sell
4,292
-100
-2% -$5.36K 0.01% 545
2014
Q1
$265K Sell
4,392
-100
-2% -$6.03K 0.01% 513
2013
Q4
$238K Sell
4,492
-300
-6% -$15.9K 0.01% 540
2013
Q3
$222K Sell
4,792
-700
-13% -$32.4K 0.01% 550
2013
Q2
$225K Buy
+5,492
New +$225K 0.01% 603